{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:13:51Z","timestamp":1780596831143,"version":"3.54.1"},"reference-count":9,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2023.1335308","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T10:32:59Z","timestamp":1700821979000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Phenotypes of myasthenia gravis, volume II"],"prefix":"10.3389","volume":"14","author":[{"given":"Hai-Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109141","DOI":"10.1016\/j.clim.2022.109141","article-title":"Diabetes mellitus aggravates humoral immune response in myasthenia gravis by promoting differentiation and activation of circulating Tfh cells","volume":"245","author":"Li","year":"2022","journal-title":"Clin Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"880045","DOI":"10.3389\/fneur.2022.880045","article-title":"Minimal manifestation status indicates a stable state in myasthenia gravis: a quantitative study","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.21037\/atm-21-1627","article-title":"A narrative review of identifying the culprit antibody in neuroimmune diseases: concept and clinical significance","volume":"11","author":"Chen","year":"2023","journal-title":"Ann Transl Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"858998","DOI":"10.3389\/fneur.2022.858998","article-title":"Analysis of nAChR autoantibodies against extracellular epitopes in MG patients","volume":"13","author":"Michail","year":"2022","journal-title":"Front Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e114060","DOI":"10.1371\/journal.pone.0114060","article-title":"Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development","volume":"9","author":"Heldal","year":"2014","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/ene.15687","article-title":"Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis","volume":"30","author":"Li","year":"2023","journal-title":"Eur J Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"839769","DOI":"10.3389\/fneur.2022.839769","article-title":"User involvement in myasthenia gravis research","volume":"13","author":"Gilhus","year":"2022","journal-title":"Front Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1474-4422(23)00364-2","article-title":"Score fluctuation might be associated with a higher placebo rate in the RAISE trial","volume":"22","author":"Li","year":"2023","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1335308\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T10:33:01Z","timestamp":1700821981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1335308\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":9,"alternative-id":["10.3389\/fneur.2023.1335308"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1335308","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"article-number":"1335308"}}